title: Placebos in clinical trials in Alzheimer disease: an international discussion.
authors.forename: P J
authors.initials: PJ
authors.lastname: Whitehouse
authors.forename: R
authors.initials: R
authors.lastname: Arizaga
authors.forename: H
authors.initials: H
authors.lastname: Brodaty
authors.forename: S
authors.initials: S
authors.lastname: Gauthier
authors.forename: N
authors.initials: N
authors.lastname: Graham
authors.forename: R C
authors.initials: RC
authors.lastname: Green
authors.forename: A
authors.initials: A
authors.lastname: Homma
authors.forename: C
authors.initials: C
authors.lastname: Mangone
authors.forename: V
authors.initials: V
authors.lastname: Senanarong
authors.forename: X H
authors.initials: XH
authors.lastname: Xu
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D001208:Asia; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000529:Complementary Therapies; D000077265:Donepezil; D020441:Ginkgo biloba; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008517:Phytotherapy; D010880:Piperidines / Q000627:therapeutic use; D015990:Placebo Effect; D010946:Plants, Medicinal; D019366:Western World
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil